CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Major trials in coronary intervention from 2018 Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document

Review Article2017 Aug;10(8). pii: e006427.

JOURNAL:Circ Cardiovasc Imaging. Article Link

Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging

Feher A, Sinusas AJ. Keywords: coronary flow reserve; coronary microvascular function; microvascular dysfunction; myocardial blood flow; myocardial perfusion imaging

FULL TEXT PDF